US-UK Drug Deal: NHS Gains New Treatments, Critics Misguided
The US-UK pharmaceutical agreement has already enabled NHS patients to access new medicines for cancer, blood disorders, and autoimmune conditions, countering alarmist claims of excess deaths.


